118 related articles for article (PubMed ID: 9330700)
1. Comparative study of CD26 as a Th1-like and CD30 as a potential Th2-like operational marker in leprosy.
Seitzer U; Scheel-Toellner D; Hahn M; Heinemann G; Mattern T; Flad HD; Gerdes J
Adv Exp Med Biol; 1997; 421():217-21. PubMed ID: 9330700
[TBL] [Abstract][Full Text] [Related]
2. Staining pattern of seven monoclonal anti-CD26 antibodies in leprosy: implications for the use of CD26 as a surrogate marker of a human Th1-like reaction.
Seitzer U; Scheel-Toellner D; Mattern T; Haas H; Flad HD; Gerdes J
Virchows Arch; 1998 Apr; 432(4):343-7. PubMed ID: 9565344
[TBL] [Abstract][Full Text] [Related]
3. Is CD30 (Ki-1) immunostaining in cutaneous eruptions useful as a marker of Th1 to Th2 cytokine switching and/or as a marker of advanced HIV-1 disease?
Smith KJ; Barrett TL; Neafie R; Tomaszewski MM; Yeager J; Nelson A; Wagner KF; Skelton HG
Br J Dermatol; 1998 May; 138(5):774-9. PubMed ID: 9666821
[TBL] [Abstract][Full Text] [Related]
4. Within the spectral forms of leprosy cellbound CD30 cannot be regarded as an operational marker for the Th-2-like reaction.
Seitzer U; Flad HD; Gerdes J
J Leukoc Biol; 1996 Feb; 59(2):311. PubMed ID: 8604005
[No Abstract] [Full Text] [Related]
5. CD26 expression in leprosy and other granulomatous diseases correlates with the production of interferon-gamma.
Scheel-Toellner D; Richter E; Toellner KM; Reiling N; Wacker HH; Flad HD; Gerdes J
Lab Invest; 1995 Nov; 73(5):685-90. PubMed ID: 7474942
[TBL] [Abstract][Full Text] [Related]
6. Crosslinking of CD30 on activated human Th clones enhances their cytokine production and downregulates the CD30 expression.
Bengtsson A; Scheynius A; Avila-Cariño J
Scand J Immunol; 2000 Dec; 52(6):595-601. PubMed ID: 11119266
[TBL] [Abstract][Full Text] [Related]
7. CD26 and CD30 expression on the surface of lymphocyte during normal pregnancy.
Hoshimoto K; Hayashi M; Ohkura T
Gynecol Obstet Invest; 2001; 52(1):9-12. PubMed ID: 11549856
[TBL] [Abstract][Full Text] [Related]
8. Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C.
Yang SS; Fu LS; Chang CS; Yeh HZ; Chen GH; Kao JH
J Gastroenterol Hepatol; 2006 Dec; 21(12):1789-93. PubMed ID: 17074015
[TBL] [Abstract][Full Text] [Related]
9. Co-expression of CD30 ligand and interleukin 4 (IL-4) receptors by acute myeloid leukaemia blasts is associated with the expansion of IL-4-producing CD30+ normal T cells.
Rossi FM; Degan M; Mazzocco FT; Di Francia R; Aldinucci D; Poletto D; Vellenga E; Pinto A; Gattei V
Br J Haematol; 2002 Apr; 117(1):59-69. PubMed ID: 11918534
[TBL] [Abstract][Full Text] [Related]
10. Not only Th2 cells but also Th1 and Th0 cells express CD30 after activation.
Bengtsson A; Johansson C; Linder MT; Halldén G; van der Ploeg I; Scheynius A
J Leukoc Biol; 1995 Dec; 58(6):683-9. PubMed ID: 7499966
[TBL] [Abstract][Full Text] [Related]
11. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
[TBL] [Abstract][Full Text] [Related]
12. Role for CD30 antigen in human T helper 2-type responses.
Romagnani S
Ciba Found Symp; 1995; 195():55-62; discussion 62-7. PubMed ID: 8724830
[TBL] [Abstract][Full Text] [Related]
13. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
Pellegrini P; Berghella AM; Contasta I; Adorno D
Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.
Keane NM; Price P; Lee S; Stone SF; French MA
Clin Exp Immunol; 2001 Oct; 126(1):111-6. PubMed ID: 11678906
[TBL] [Abstract][Full Text] [Related]
15. Changes in plasma soluble CD26 and CD30 during pregnancy: markers of Th1/Th2 balance?
Hoshimoto K; Ohta N; Ohkura T; Inaba N
Gynecol Obstet Invest; 2000; 50(4):260-3. PubMed ID: 11093050
[TBL] [Abstract][Full Text] [Related]
16. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD30 is more relevant to disease activity of atopic dermatitis than soluble CD26.
Katoh N; Hirano S; Suehiro M; Ikenaga K; Yamashita T; Sugawara N; Yasuno H
Clin Exp Immunol; 2000 Aug; 121(2):187-92. PubMed ID: 10931130
[TBL] [Abstract][Full Text] [Related]
18. Functional heterogeneity among CD4+ T-cell clones from blood and skin lesions of leprosy patients. Identification of T-cell clones distinct from Th0, Th1 and Th2.
Howe RC; Wondimu A; Demissee A; Frommel D
Immunology; 1995 Apr; 84(4):585-94. PubMed ID: 7790032
[TBL] [Abstract][Full Text] [Related]
19. CD30 expression does not discriminate between human Th1- and Th2-type T cells.
Hamann D; Hilkens CM; Grogan JL; Lens SM; Kapsenberg ML; Yazdanbakhsh M; van Lier RA
J Immunol; 1996 Feb; 156(4):1387-91. PubMed ID: 8568238
[TBL] [Abstract][Full Text] [Related]
20. CD30, Th2 cytokines and HIV infection: a complex and fascinating link.
Del Prete G; Maggi E; Pizzolo G; Romagnani S
Immunol Today; 1995 Feb; 16(2):76-80. PubMed ID: 7888070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
